Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Intarcia files for IPO; withdrawn

Executive Summary

Citing poor market conditions, Intarcia Therapeutics (acquires and develops drugs for cancer and infectious diseases) has withdrawn its intial public offering in which it planned to sell 5mm shares priced between $12 and $14 each.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
Deal Status
  • Withdrawn
Deal Type
  • Financing
    • IPO

Related Companies

UsernamePublicRestriction

Register